You are here:
Two key factors set the Vaccine Alliance apart from other actors in the field of international health aid:
In this section, we explain Gavi’s partnership model and profile the role of each of the Vaccine Alliance’s members.
The Bill & Melinda Gates Foundation's initial five-year pledge of US$ 750 million in 1999 provided the seed money to launch Gavi.
As a co-founder of Gavi and the UN's specialist agency on global health issues, WHO is a key implementing partner.
As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the Vaccine Alliance.
The World Bank brings the expertise of the world's biggest source of development assistance to the Vaccine Alliance.
Developing countries are the most important part of the Vaccine Alliance. They apply for support, manage grants and finance immunisation programmes.
Industrialised country governments' experience in overseas development and funding ensure health is prioritised in aid programmes.
CSOs help deliver vaccines to remote communities, implement vaccine programmes and advocate for immunisation.
Gavi aims to make vaccines more affordable for low-income countries by expanding the range of suppliers to include developing country manufacturers.
Gavi harnesses the technical expertise of the IFPMA to ensure new vaccines are available that address the needs of developing countries.
Partnership with the research community allows Gavi to tap in the latest information and thinking from the scientific, medical and product delivery communities.
Gavi support is available to the 73 poorest countries in the world. Over 20 countries are projected to graduate from Gavi’s support by 2020.
24 July 2015
Malaria vaccine: How good is good enough?
23 July 2015
Sudan's other crisis
03 July 2015
Investment in child health in world's poorest countries saves 34m lives
01 May 2015
Immunisation gives children chance to live life to full potential
22 April 2015
The imperative of closing the immunization gap
24 March 2015
Be Bold: How Gavi Will Immunise Another 300 Million Children
18 March 2015
How to Fight the Next Epidemic
The New York Times
Share the risks of Ebola vaccine development
06 March 2015
Bill Gates: Why I'm betting on the Gulf to help fight extreme poverty and disease
03 March 2015
Ebola vaccine research in Africa
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here